NCT02217267View on ClinicalTrials.gov

Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 1, 2014

Primary Completion Date

December 29, 2017

Study Completion Date

February 28, 2018

Conditions
Peripheral Neuropathy
Interventions
DRUG

Lidocaine

Lidocaine 3 mg/kg dilute in Normal Saline to 50 ml intravenous infusion in 1 hour

DRUG

Placebo

Trial Locations (1)

10700

Faculty of medicine Siriraj Hospital Mahidol University, Bangkoknoi

All Listed Sponsors
lead

Mahidol University

OTHER

NCT02217267 - Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain | Biotech Hunter | Biotech Hunter